{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:05:27Z","timestamp":1790744727271,"version":"4.1.0"},"reference-count":29,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2002,8,1]]},"abstract":"<jats:p> PURPOSE: To evaluate the incidence and clinical significance of partial tandem duplications (PTDs) of the mixed lineage leukemia (MLL) gene in a large series of newly diagnosed adult patients (16 to 60 years old) with acute myeloid leukemia (AML) intensively treated within the multicenter treatment trials AML-HD93 and AML-HD98A. <\/jats:p><jats:p> PATIENTS AND METHODS: Identification of MLL PTD was performed centrally using Southern blot analysis in pretreatment samples from 525 of 683 assessable patients. PTD was confirmed by polymerase chain reaction (PCR) and sequencing of the PCR products. <\/jats:p><jats:p> RESULTS: MLL PTD was identified in none of the 129 patients with t(8;21), inv(16), and t(15;17); in 19 (7.7%) of 247 patients with normal karyotype; and in 10 (8.5%) of 119 patients with all other abnormalities, with 30 cases of t(11q23) excluded. In the group of patients with a normal karyotype, there was no difference in the presenting clinical features between the PTD-positive and the PTD-negative cases. Sixteen (89%) of the 18 assessable PTD-positive patients and 158 (78%) of the 203 PTD-negative patients achieved a complete remission. After a median follow-up time of 19 months, 11 of the 16 PTD-positive patients relapsed compared with 54 of the 158 PTD-negative patients; the median remission durations of the PTD-positive and the PTD-negative groups were 7.75 months and 19 months, respectively (P &lt; .001). Multivariate analysis identified the MLL PTD status as the single prognostic factor for remission duration. <\/jats:p><jats:p> CONCLUSION: Within the subgroup of young adult AML patients with normal karyotype, MLL PTD is associated with short remission duration. <\/jats:p>","DOI":"10.1200\/jco.2002.09.088","type":"journal-article","created":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T21:58:26Z","timestamp":1033509506000},"page":"3254-3261","source":"Crossref","is-referenced-by-count":268,"title":["Prognostic Significance of Partial Tandem Duplications of the <i>MLL<\/i> Gene in Adult Patients 16 to 60 Years Old With Acute Myeloid Leukemia and Normal Cytogenetics: A Study of the Acute Myeloid Leukemia Study Group Ulm"],"prefix":"10.1200","volume":"20","author":[{"given":"Konstanze","family":"D\u00f6hner","sequence":"first","affiliation":[{"name":"From the Department of Internal Medicine III, University of Ulm, Ulm, and Deutsches Krebsforschungszentrum, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Tobis","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine III, University of Ulm, Ulm, and Deutsches Krebsforschungszentrum, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Ulrich","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine III, University of Ulm, Ulm, and Deutsches Krebsforschungszentrum, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Fr\u00f6hling","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine III, University of Ulm, Ulm, and Deutsches Krebsforschungszentrum, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Benner","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine III, University of Ulm, Ulm, and Deutsches Krebsforschungszentrum, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Schlenk","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine III, University of Ulm, Ulm, and Deutsches Krebsforschungszentrum, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"D\u00f6hner","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine III, University of Ulm, Ulm, and Deutsches Krebsforschungszentrum, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1-111472","doi-asserted-by":"publisher","DOI":"10.1053\/beha.2000.0114"},{"key":"R2-111472","unstructured":"Bloomfield  CD,   Lawrence  D,   Byrd  JC,  et al:   Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.  Cancer Res 58:  4173,1998-4179,"},{"key":"R3-111472","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.7.2322"},{"key":"R4-111472","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.13.4075"},{"key":"R5-111472","unstructured":"Caligiuri  MA,   Schichmann  SA,   Strout  MP,  et al:   Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations.  Cancer Res 54:  370,1994-373,"},{"key":"R6-111472","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309233291302"},{"key":"R7-111472","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90603-A"},{"key":"R8-111472","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050511"},{"key":"R9-111472","unstructured":"Caligiuri  MA,   Strout  MP,   Schichmann  SA,  et al:   Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11.  Cancer Res 56:  1418,1996-1425,"},{"key":"R10-111472","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.8.3899"},{"key":"R11-111472","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.5.2390"},{"key":"R12-111472","unstructured":"Marcucci  G,   Strout  MP,   Bloomfield  CD,  et al:   Detection of unique ALL1 (MLL) fusion transcripts in normal human bone marrow and blood:  Distinct origin of normal versus leukemic ALL1 fusion transcripts.   Cancer Res 58:  790,1998-793,"},{"key":"R13-111472","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.5.1728"},{"key":"R14-111472","unstructured":"Caligiuri  MA,   Strout  MP,   Lawrence  D,  et al:   Rearrangement of the ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics.  Cancer Res 58:  55,1998-59,"},{"key":"R15-111472","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401773"},{"key":"R16-111472","doi-asserted-by":"crossref","unstructured":"D\u00f6hner  H,   Fischer  K,   del Valle  F,  et al:   Stratification of postremission therapy in adult acute myeloid leukemia according to the karyotype:  First results of the AML HD93 multicenter treatment trial.   Blood 90:  584a,1997   (suppl 1)","DOI":"10.1007\/978-3-642-71960-8_119"},{"key":"R17-111472","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-4-620"},{"key":"R19-111472","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.10.3962.bloodjournal88103962"},{"key":"R20-111472","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.08.155"},{"key":"R21-111472","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.13.6236"},{"key":"R22-111472","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90602-9"},{"key":"R23-111472","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.10.4738"},{"key":"R24-111472","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.5.813"},{"key":"R25-111472","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780050306"},{"key":"R26-111472","doi-asserted-by":"crossref","unstructured":"Kaplan  EL,   Meier  P:   Non-parametric estimation from incomplete observation.  J Am Stat Assoc 47:  457,1958-481,","DOI":"10.1080\/01621459.1958.10501452"},{"key":"R27-111472","unstructured":"Mantel  N,   Haenszel  W:   Statistical aspects of the analysis of data from retrospective studies of disease.  J Natl Cancer Inst 22:  719,1959-748,"},{"key":"R28-111472","doi-asserted-by":"crossref","unstructured":"Cox  DR:   Regression models and life tables.  J R Stat Soc B 34:  187,1972-220,","DOI":"10.1111\/j.2517-6161.1972.tb00899.x"},{"key":"R29-111472","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402423"},{"key":"R30-111472","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.3.565"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2002.09.088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:47:42Z","timestamp":1653515262000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2002.09.088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8,1]]},"references-count":29,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2002,8,1]]}},"alternative-id":["10.1200\/JCO.2002.09.088"],"URL":"https:\/\/doi.org\/10.1200\/jco.2002.09.088","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8,1]]}}}